Your browser doesn't support javascript.
loading
A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alpha) vs. Eprex® in patients with anaemia of chronic renal failure.
Lim, Soo Kun; Goh, Bak Leong; Visvanathan, Ravindran; Kim, Su Hyun; Jeon, Jin Seok; Kim, Sung Gyun; Chang, Jae Hyun; Lim, Chun Soo; Morad, Zaki.
Afiliação
  • Lim SK; Renal Division, Department of Medicine, Faculty of Medicine, University of Malaya, 59100, Kuala Lumpur, Malaysia. limsk@ummc.edu.my.
  • Goh BL; Serdang Hospital, Kajang, Malaysia.
  • Visvanathan R; Prince Court Medical Centre, Kuala Lumpur, Malaysia.
  • Kim SH; Chung-Ang University Hospital, Seoul, South Korea.
  • Jeon JS; Soonchunhyang University Hospital, Seoul, South Korea.
  • Kim SG; Hallym University Sacred Heart Hospital, Anyang, South Korea.
  • Chang JH; Gil Medical Centre, Gachon University College of Medicine, Incheon, South Korea.
  • Lim CS; Seoul National University Boramae Medical Centre, Seoul, South Korea.
  • Morad Z; KPJ Ampang Puteri Specialist Hospital, Ampang, Malaysia.
BMC Nephrol ; 22(1): 391, 2021 11 25.
Article em En | MEDLINE | ID: mdl-34823497

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Epoetina alfa / Hematínicos / Anemia Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Epoetina alfa / Hematínicos / Anemia Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article